Skip to Content

Tag: CPAP recall


On the Editor's Desk

A fine line 

May 18, 2022Liz Beaulieu, Editor

Am I the only one getting CPAP shortage vibes from the baby formula shortage?  I’m not going to lie. The formula shortage wasn’t fully on my radar until recently. With a seven-year-old, my days of buying formula are long over. But seven years ago, it would have been a different story, as my daughter was 100% formula fed. (My breastfeeding story, by the way, is not uncommon. Difficulty with latching. Supply issues with pumping. There is no shame here.)  I can’t imagine...

Consolidation, CPAP recall, CPAP shortage


Read Full Articlered right arrow icon

Mick Farrell

Vendors

ResMed: ‘This is a humanitarian emergency’

April 29, 2022Liz Beaulieu, Editor

SAN DIEGO – ResMed has “five lines of work” to pump more of its CPAP devices into the market amid ongoing supply chain challenges, including a new AirSense 10 card-to-cloud device, says CEO Mick Farrell.  The company has launched the device – which is “basically an AirSense 10 without the cell chip in it,” says Jim Hollingshead, president, Sleep and Respiratory Care Business – only in select markets, but it’s in the process of adding markets.  “Look,...

AirSense, CPAP recall, Mick Farrell, ResMed


Read Full Articlered right arrow icon

Vendors

ResMed: ‘Our third-quarter results reflect strong performance’

April 28, 2022HME News Staff

SAN DIEGO – ResMed reported revenue increased 12% to $864.5 million in its third quarter fiscal year 2022. The company reported revenue, excluding software-as-a-service, increased 18% in the United States, Canada and Latin America, primarily due to a recall by one of its competitors and a recovery of core sleep patient flow that has been impacted by the COVID-19 pandemic. “Our third-quarter results reflect strong performance across our business, resulting in double-digit top-line...

CPAP Devices, CPAP recall, Financial Results, ResMed, Sleep Therapy


Read Full Articlered right arrow icon

Vendors

Philips increases provision for recall 

April 25, 2022HME News Staff

AMSTERDAM, the Netherlands – Philips Respironics recorded EUR 165 million in additional provisions related to its recall of certain CPAP devices in the first quarter of 2022, according to the company’s financial results.  The company recorded a EUR 65 million increase in the field action provision in the quarter to account for the higher expected volume of devices eligible for remediation and the higher communication costs. It recorded a further EUR 100 million provision...

CPAP recall, Philips Respironics


Read Full Articlered right arrow icon

On the Editor's Desk

Silos, recall and more

April 19, 2022Liz Beaulieu, Editor

The most read stories of the first quarter of 2022 point to a lot of changes in the HME industry right now.  Our No. 1 most read story, “Owens & Minor buys Apria, reaches deeper into home care,” points to an accelerating trend in the larger health care industry where vertical silos are disintegrating. Here, we see a global distributor and logistics company buy an HME provider (this follows its previous acquisition of Byram Healthcare). These kinds of deals have happened before,...

CPAP recall, health care silos, Oxygen NCD


Read Full Articlered right arrow icon

News

In brief: CPAP preferences shift, Belluscura snags gov’t contract, CMS invests in home care 

April 8, 2022HME News Staff

NEW YORK – HME providers expect to shift an average of 58.4% of their Philips Respironics flow generator purchases and an average of 30.2% of their mask purchases to other companies due to the recall, according to the first quarter HME Sleep and Oxygen Survey from Needham.  That’s up from the 56% and 23.1%, respectively, reported in the third quarter survey.  “ResMed should gain market share over the (next 12 months),” the survey states. “Respondents...

Belluscura, CPAP recall, CPAP Therapy, Money Follows the Person, Portable Oxygen Concentrator


Read Full Articlered right arrow icon

News

Report: Recall causes shifts in sleep therapy market

April 5, 2022HME News Staff

NEW YORK – HME providers expect to shift an average of 58.4% of their Philips Respironics flow generator purchases and an average of 30.2% of their mask purchases to other companies due to the recall, according to the first quarter HME Sleep and Oxygen Survey from Needham.  That’s up from the 56% and 23.1%, respectively, reported in the third quarter survey.  “ResMed should gain market share over the (next 12 months),” the survey states. “Respondents...

CPAP recall, Needham survey, Philips Respironics, ResMed


Read Full Articlered right arrow icon

Eric Mongeau

Specialty Providers

Supply chain and recall: Aeroflow uses size to press narrative

April 1, 2022Theresa Flaherty, Managing Editor

ASHEVILLE, N.C. – Aeroflow Healthcare has ramped up outreach efforts to make sure payers and lawmakers understand the impact of a global semiconductor chip shortage and a CPAP device recall on providers and patients.  “We wanted to take an independent stance and see what action we could drum up beyond what we’re already involved in with AAHomecare and VGM,” said Eric Mongeau, national director for Aeroflow Sleep. “This aligns perfectly with our responsibility...

Aeroflow Healthcare, CPAP recall, supply chain challenges


Read Full Articlered right arrow icon

Mick Farrell

Vendors

ResMed makes dent in $300M goal

October 29, 2021Liz Beaulieu, Editor

SAN DIEGO – ResMed posted a 40% increase in sales for CPAP devices in the U.S., Canada and Latin America in the first quarter of the company’s fiscal year 2022, driven in part by increased demand created by a competitor’s recall.  Company officials previously said they expect the recall to result in incremental revenue from device sales of $300 million to $350 million for fiscal year 2022 but meeting that goal will depend on their ability to address supply chain issues.  “We...

CPAP Machines, CPAP recall, ResMed


Read Full Articlered right arrow icon